PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria–nucleus signalling
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Over the past two decades, a complex nuclear transcriptional machinery controlling mitochondrial biogenesis and function has been described. Central to this network are the PGC-1 family coactivators, characterised as master regulators of mitochondrial biogenesis. Recent literature has identified a broader role for PGC-1 coactivators in both cell death and cellular adaptation under conditions of stress, here reviewed in the context of the pathology associated with cancer, neurodegeneration and cardiovascular disease. Moreover, we propose that these studies also imply a novel conceptual framework on the general role of mitochondrial dysfunction in disease. It is now well established that the complex nuclear transcriptional control of mitochondrial biogenesis allows for adaptation of mitochondrial mass and function to environmental conditions. On the other hand, it has also been suggested that mitochondria alter their function according to prevailing cellular energetic requirements and thus function as sensors that generate signals to adjust fundamental cellular processes through a retrograde mitochondria-nucleus signalling pathway. Therefore, altered mitochondrial function can affect cell fate not only directly by modifying cellular energy levels or redox state, but also indirectly, by altering nuclear transcriptional patterns. The current literature on such retrograde signalling in both yeast and mammalian cells is thus reviewed, with an outlook on its potential contribution to disease through the regulation of PGC-1 family coactivators. We propose that further investigation of these pathways will lead to the identification of novel pharmacological targets and treatment strategies to combat disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex
Zhang, Q., Wang, S.-Y., Fleuriel, C., Leprince, D., Rocheleau, J. V., Piston, D. W., & Goodman, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610590104 · Cited by 171
RetractedMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“Alongside suppression of the cell death programme, cancer cells must also alter intracellular metabolism to meet the demands of rapid cellular proliferation in the unique tumour microenvironment, referred to as metabolic reprogramming (DeBerardinis et al., 2008).”
BackgroundClassification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · cited 1×
“PGC-1αmay potentially stimulate both cell growth and cancer cell survival throughHIF TFs, since PGC-1α overexpression in rat skeletalmyotubes upregulatedHIF-2α, a TF previously associated with tumourigenesis and chemoresistance (Majmundar et al., 2010; Rasbach et al., 2010; Roberts et al., 2009).”
BackgroundSt-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · cited 10×
“SH-SY5Y cells overexpressing PGC-1α were also protected from H2O2 treatment, with a reduction in caspase-3 activation (Cowell et al., 2009; St-Pierre et al., 2006).”
BackgroundInfluentialMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 3×
“…the retrograde signals involved are poorly characterised, and the examples presented involve a number of pathways and regulators upstream of PGC-1 family expression and activation, as detailed in the first section and recently reviewed in (Hock and Kralli, 2009; Lin et al., 2005a; Scarpulla, 2011).”
BackgroundWilliamson, D., Lund, P., & Krebs, H. (1967) · Biochemical Journal · doi:10.1042/bj1030514 · Cited by 1,871 · cited 2×
“However, since the free cytoplasmic and presumably nuclear NADH/NAD+ ratio was estimated to approximately 1:700 (Williamson et al., 1967), even substantial reduction in NADH levels would not lead to significant changes in the absolute [NAD+].”
BackgroundTranscriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444 · cited 2×
“…ROS signalling involving Mcl-1 and HIF1α has been shown to contribute to the development of a metastatic phenotype (Ishikawa et al., 2008a; Ishikawa et al., 2008b), while Akt hyperphosphorylation in the absence of elevated ROS was also able to elicit a similar effect (Kulawiec et al.,…”
BackgroundMetabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Scarpulla, R. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.019 · Cited by 1,281
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., et al. (2003) · Science · doi:10.1126/science.1079368 · Cited by 1,243
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
Radical-free biology of oxidative stress
Jones, D. P. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00283.2008 · Cited by 1,213
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
Arany, Z., Foo, S.-Y., Ma, Y., Ruas, J. L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S. M., et al. (2008) · Nature · doi:10.1038/nature06613 · Cited by 1,054
SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α
Nemoto, S., Fergusson, M. M., & Finkel, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501485200 · Cited by 1,047 · cited 1×
“According to this pathway, activation of Sirt1 in turn would lead to the activation of PGC-1α, mediating mitochondrial biogenesis to re-establish cellular energy levels (Nemoto et al., 2005).”
BackgroundCui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Shin, J.-H., Ko, H. S., Kang, H., Lee, Y., Lee, Y.-I., Pletinkova, O., Troconso, J. C., Dawson, V. L., & Dawson, T. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.010 · Cited by 953 · cited 1×
“Such repression of PGC-1α has been attributed to mutant nuclear huntingtin (Cui et al., 2006) or a parkin dysfunction mediated mitochondrial-nuclear pathway (Shin et al., 2011).”
BackgroundLeone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Butow, R. A., & Avadhani, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00179-0 · Cited by 882
Cell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832 · cited 3×
“rupture of cellular organelles and the plasmamembrane,whichmay follow loss of ΔΨm during mitochondrial permeability transition (Galluzzi et al., 2007; Halestrap, 2009; Kroemer et al., 2009).”
BackgroundMitochondrial protein import: from proteomics to functional mechanisms
Schmidt, O., Pfanner, N., & Meisinger, C. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2959 · Cited by 717
Mitochondrial retrograde signaling
Liu, Z., & Butow, R. A. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090613 · Cited by 680
Mitochondrial DNA mutations and human disease
Tuppen, H. A. L., Blakely, E. L., Turnbull, D. M., & Taylor, R. W. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.09.005 · Cited by 676 · cited 2×
“ing point mutations and rearrangements, have been found to cause a range of diseases (Tuppen et al., 2010; Wallace, 2010).”
BackgroundNitrogen regulation in Saccharomyces cerevisiae
Magasanik, B., & Kaiser, C. A. (2002) · Gene · doi:10.1016/s0378-1119(02)00558-9 · Cited by 669 · cited 2×
“, 2005) and (iii) the anaplerosis of a truncated TCA cycle in the absence of succinate dehydrogenase activity in order to provide substrates for glutamate and lysine synthesis, ensuring the requirement for nitrogen for anabolic reactions is fulfilled (Epstein et al., 2001; Magasanik and Kaiser, 2002).”
BackgroundThe Mitochondrial Proteome and Human Disease
Calvo, S. E., & Mootha, V. K. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141720 · Cited by 590 · cited 1×
“…(iii) synthesis of the few, but nonetheless fundamental, mtDNA encoded protein components of the electron transport chain (ETC) in the matrix (Calvo and Mootha, 2010; Schmidt et al., 2010; Sickmann et al., 2003); and (iv) replication of themitochondrial genome and translational machinery…”
BackgroundWeydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.004 · Cited by 562
PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells
VALLE, I., ALVAREZBARRIENTOS, A., ARZA, E., LAMAS, S., & MONSALVE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.026 · Cited by 556 · cited 3×
“As for neuron models, increased expression of PGC-1α in human vascular endothelial cells (HUVEC) led to mitochondrial biogenesis and an increased complement of ROS detoxification proteins, includingMnSOD (Valle et al., 2005).”
BackgroundLin, J., Puigserver, P., Donovan, J., Tarr, P., & Spiegelman, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100631200 · Cited by 552 · cited 2×
“, named PGC-1β (Kressler et al., 2002; Lin et al., 2002a) and PGC-1α related coactivator (Andersson and Scarpulla, 2001) (PRC), as well as a truncated alternatively spliced isoform, NT-PGC-1α (Zechner et al., 2010; Zhang et al., 2009).”
BackgroundNuclear control of respiratory gene expression in mammalian cells
Scarpulla, R. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20743 · Cited by 489 · cited 2×
“…set of DNA binding transcription factors (TFs) responsible for the induction of cytochrome c and cytochrome oxidase subunit genes, thus named nuclear respiratory factor 1 and 2 (NRF1 and 2, the latter is a homologue of the mouse GA binding protein [GABP], for reviews see (Scarpulla, 2006, 2008a)).”
BackgroundRegulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex
Kajimura, S., Seale, P., Tomaru, T., Erdjument-Bromage, H., Cooper, M. P., Ruas, J. L., Chin, S., Tempst, P., Lazar, M. A., & Spiegelman, B. M. (2008) · Genes & Development · doi:10.1101/gad.1666108 · Cited by 468 · cited 4×
“Alternatively, it has been recently proposed that increased AMP/ATP ratios, due tomitochondrial dysfunctionwould lead to activation of AMPK, which has been shown to signal energy depletion to Sirt1 by increasing absolute NAD+ levels (reviewed in (Jeninga et al., 2010)).”
BackgroundInfluentialCzubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337639100 · Cited by 418 · cited 1×
“Indeed, PGC-1α has been suggested to play a key role in physiological cardiomyocyte metabolism and growth (Arany et al., 2005; Czubryt et al., 2003; Huss and Kelly, 2004).”
BackgroundRussell, L. K., Mansfield, C. M., Lehman, J. J., Kovacs, A., Courtois, M., Saffitz, J. E., Medeiros, D. M., Valencik, M. L., McDonald, J. A., & Kelly, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000117088.36577.eb · Cited by 402
Genome-wide responses to mitochondrial dysfunction
Epstein, C. B., Waddle, J. A., Hale, W., Davé, V., Thornton, J., Macatee, T. L., Garner, H. R., & Butow, R. A. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.2.297 · Cited by 389 · cited 4×
“transport chain by FCCP or mutations in TCA cycle enzymes compared to those genes of which expression is altered following mtDNA depletion, further indicating that response pathways specific to the site of a metabolic defect exist (Epstein et al., 2001; McCammon et al., 2003).”
BackgroundInfluentialArany, Z., Novikov, M., Chin, S., Ma, Y., Rosenzweig, A., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603615103 · Cited by 374
Biswas, G., Adebanjo, O. A., Freedman, B. D., Anandatheerthavarada, H. K., Vijayasarathy, C., Zaidi, M., Kotlikoff, M., & Avadhani, N. G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.522 · Cited by 369 · cited 7×
“These pathways include calcineurin mediated activation of NFAT signalling coupled to increased activity of ATF2, activation of NFκB (Biswas et al., 1999; Biswas et al., 2008), MAPK (Amuthan et al., 2002; Luo et al., 1997) and protein kinase C (PKC) (Amuthan et al., 2001), as well as CamKIV mediated…”
BackgroundInfluentialHigh aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain
Lin, M. T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.133 · Cited by 366
Irrcher, I., Ljubicic, V., & Hood, D. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00267.2007 · Cited by 356
Lai, L., Leone, T. C., Zechner, C., Schaeffer, P. J., Kelly, S. M., Flanagan, D. P., Medeiros, D. M., Kovacs, A., & Kelly, D. P. (2008) · Genes & Development · doi:10.1101/gad.1661708 · Cited by 326 · cited 4×
“Genetic approaches have established the complimentary function of PGC-1α and PGC-1β in maintaining an appropriate mitochondrial density in tissues with high energy demand, as clearly demonstrated by the recently created double knockout mice, which show markedly reduced mitochondrial number and size in brown adipose ti…”
BackgroundInfluentialA Common Set of Gene Regulatory Networks Links Metabolism and Growth Inhibition
Cam, H., Balciunaite, E., Blais, A., Spektor, A., Scarpulla, R. C., Young, R., Kluger, Y., & Dynlacht, B. D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.037 · Cited by 322
Ling, C., Poulsen, P., Carlsson, E., Ridderstråle, M., Almgren, P., Wojtaszewski, J., Beck-Nielsen, H., Groop, L., & Vaag, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21889 · Cited by 300
Lelliott, C. J., Medina-Gomez, G., Petrovic, N., Kis, A., Feldmann, H. M., Bjursell, M., Parker, N., Curtis, K., Campbell, M., Hu, P., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040369 · Cited by 280 · cited 1×
“…TFs extends beyond transcripts encoding mitochondrial proteins (Cam et al., 2004) to those required for broad cellular function, and cell type specific TFs exist, such as myocyte enhancer factor-2 (MEF2) and E-box binding factors in striated muscle (Lenka et al., 1996; Wan and Moreadith, 1995).”
BackgroundZechner, C., Lai, L., Zechner, J. F., Geng, T., Yan, Z., Rumsey, J. W., Collia, D., Chen, Z., Wozniak, D. F., Leone, T. C., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.008 · Cited by 274 · cited 4×
“, named PGC-1β (Kressler et al., 2002; Lin et al., 2002a) and PGC-1α related coactivator (Andersson and Scarpulla, 2001) (PRC), as well as a truncated alternatively spliced isoform, NT-PGC-1α (Zechner et al., 2010; Zhang et al., 2009).”
BackgroundInfluentialTaherzadeh-Fard, E., Saft, C., Akkad, D. A., Wieczorek, S., Haghikia, A., Chan, A., Epplen, J. T., & Arning, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-32 · Cited by 134 · cited 2×
“…be associated with single nucleotide polymorphisms in the gene encoding PGC-1α (PPARGC1A) (Clark et al., 2011; Weydt et al., 2009), whilst sequence variations in PGC-1α target genes such as TFAM and NRF-1 were identified in AD and HD patients (Maruszak et al., 2011; Taherzadeh-Fard et al., 2011).”
BackgroundSomatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
Simon, D. K., Lin, M. T., Zheng, L., Liu, G.-J., Ahn, C. H., Kim, L. M., Mauck, W. M., Twu, F., Beal, M. F., & Johns, D. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00037-x · Cited by 118
The biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108 · cited 2×
“A detailed summary of these works is beyond the scope of this review, for recent updates see (Handschin, 2009; Wenz, 2009, 2011; Zorzano et al., 2010).”
BackgroundMethodRoberts, A. M., Watson, I. R., Evans, A. J., Foster, D. A., Irwin, M. S., & Ohh, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1770 · Cited by 88
Zhang, X., & Moye-Rowley, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106285200 · Cited by 84
Regulation of Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator PGC-1α
Bianchi, K., Vandecasteele, G., Carli, C., Romagnoli, A., Szabadkai, G., & Rizzuto, R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401784 · Cited by 60
Self-citationSkeletal muscle gene expression profiling in mitochondrial disorders
Crimi, M., Bordoni, A., Menozzi, G., Riva, L., Fortunate, F., Galbiati, S., Del Bo, R., Pozzoli, U., Bresolin, N., & Comi, G. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3045fje · Cited by 56
Cited by
LeBleu, V. S., O’Connell, J. T., Gonzalez Herrera, K. N., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A., Domingos Chinen, L. T., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,404
Systems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
“signaling and the activation of a peroxisome proliferatoractivated receptor g, coactivator 1b (PPARGC1B)-dependent (but mitochondrion-independent) signal transduction cascade.(150,152) Moreover, both rho cells and cells depleted of”
BackgroundSelf-citationRyan, S. D., Dolatabadi, N., Chan, S. F., Zhang, X., Akhtar, M. W., Parker, J., Soldner, F., Sunico, C. R., Nagar, S., Talantova, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.009 · Cited by 434
De Clercq, I., Vermeirssen, V., Van Aken, O., Vandepoele, K., Murcha, M. W., Law, S. R., Inzé, A., Ng, S., Ivanova, A., Rombaut, D., et al. (2013) · The Plant Cell · doi:10.1105/tpc.113.117168 · Cited by 373
After the banquet: Mitochondrial biogenesis, mitophagy, and cell survival
Zhu, J., Wang, K. Z., & Chu, C. T. (2013) · Autophagy · doi:10.4161/auto.24135 · Cited by 293
Metadata
- Authors
- Jones, A. W. E., Yao, Z., Vicencio, J. M., Karkucinska-Wieckowska, A., & Szabadkai, G.
- Venue
- Mitochondrion
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 12
- Issue
- 1
- Pages
- 86-99
- ISSN
- 1567-7249 (ISSN-L)
- OpenAlex
- W1988834592
- Cited by
- 147
- References
- 53
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.